Back to top
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Pentair plc (PNR) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Pentair plc (PNR) - free report >>
Image: Bigstock
New Strong Sell Stocks for November 2nd
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
• Alexion Pharmaceuticals, Inc. develops pharmaceutical products for the treatment of heart disease, and inflammation, diseases of the immune system and cancer in humans. The Zacks Consensus Estimate for its current year earnings has been revised 0.3% downward over the last 30 days.
• Oshkosh Corporation (OSK - Free Report) is a leading designer, manufacturer and marketer of a broad range of specialty access equipment, commercial, fire & emergency and military vehicles and vehicle bodies. The Zacks Consensus Estimate for its current year earnings has declined 1.9% over the last 30 days.
• Pentair plc (PNR - Free Report) delivers industry-leading products, services and solutions for its customers' diverse needs in water and other fluids, thermal management and equipment protection. It has seen the Zacks Consensus Estimate for its current year earnings being revised 1.2% downward over the last 30 days.
• US Ecology, Inc. provides radioactive, PCB, hazardous, and non-hazardous waste services. The Zacks Consensus Estimate revision for its current year earnings was a negative of 13.5% over the last 30 days.
• Proto Labs, Inc. (PRLB - Free Report) is an online and technology-enabled quick-turn manufacturer of custom parts for prototyping and short-run production. The Zacks Consensus Estimate for its current year earnings has moved 0.6% lower over the last 30 days.
View the entire Zacks Rank #5 List.